Concepedia
Statistics
Publications
6
Citations
237
H-Index
Active since
2023
Affiliations
Novartis (United States)(Current)
University of California San Diego
Massachusetts General Hospital
Harvard University
Baim Institute for Clinical Research
Xingdi Hu is an author at Novartis (United States) specializing in atherosclerosis, metabolic syndrome, and epidemiology.
Top concepts
MedicineEpidemiologyPharmacologyPublic HealthAtherosclerosisVascular BiologyMetabolic SyndromeCardiovascular DiseaseCoronary Heart DiseaseCardiovascular Epidemiology
Publications per year
2023–2024
Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes
Thomas Gilliland, Yuxi Liu, Reza Mohebi et al. · Journal of the American College of Cardiology · 2023 · 111 citations · Full text
Oxidized Phospholipids, Metabolic Syndrome, Lipid Disorder +14
Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort
Nathan D. Wong, Wenjun Fan, Xingdi Hu et al. · Journal of the American College of Cardiology · 2024 · 72 citations · Full text
Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study
James L. Januzzi, Roland R.J. van Kimmenade, Yuxi Liu et al. · Journal of the American Heart Association · 2024 · 16 citations · Full text
Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study
Xingdi Hu, Joaquim Cristino, Raju Gautam et al. · American Journal of Preventive Cardiology · 2023 · 14 citations · Full text
Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems
Nishant Shah, Hillary Mulder, Elizabeth Lydon et al. · Journal of the American Heart Association · 2024 · 14 citations · Full text
1–5 of 6